Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, MA, Vertex today has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia. Read more about our global locations.
Our Investor Relations team participates in many investor events and presentations throughout the year, and we invite you to sign up for our email and news alerts and listen to archived and live presentations.
Latest Press Releases:
To receive Vertex's press releases by email, please sign up for Email & News Alerts.
With two approved medicines and our broad pipeline, Vertex is well positioned to become a global business focused on creating additional medicines for people with serious diseases.
– Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex.